High prevalence of elevated lead levels in pediatric dialysis patients

Guido Filler1, Elizabeth Roach, Abeer Yasin

  • 1Department of Pediatrics, Schulich School of Medicine & Dentistry, London, ON, Canada. guido.filler@lhsc.on.ca

Insights

Pediatric chronic kidney disease (CKD) patients on calcium carbonate treatment showed elevated blood lead (Pb) levels. Monitoring lead is crucial for these vulnerable patients.

Area of Science:

  • Nephrology
  • Environmental Health
  • Pediatric Medicine

Background:

  • Concerns arose regarding lead (Pb) contamination in calcium carbonate used for hyperphosphatemia treatment in pediatric chronic kidney disease (CKD).
  • A quality-assurance investigation was conducted to measure blood Pb levels in pediatric CKD patients.

Purpose of the Study:

  • To assess blood lead levels in pediatric patients with chronic kidney disease (CKD).
  • To investigate the correlation between lead levels, kidney function, and calcium carbonate dosage.

Main Methods:

  • Blood lead (Pb) levels were measured using high-resolution sector field inductively coupled mass spectrometry.
  • Kidney function was assessed via cystatin C estimated glomerular filtration rate (eGFR).
  • Lead levels in dialysis feed water were also analyzed.

Main Results:

  • Pediatric CKD patients exhibited significantly higher mean blood Pb concentrations (21.1 ± 15.8 µg/l) compared to healthy controls.
  • Elevated lead levels correlated with red blood cell distribution width, eGFR, and calcium carbonate dose.
  • Lead levels in dialysis feed water were below the accepted limit.

Conclusions:

  • A high prevalence of elevated blood lead levels was found in pediatric CKD patients.
  • Lead levels were correlated with calcium carbonate dose and glomerular filtration rate (GFR).
  • Routine monitoring of lead levels is recommended for pediatric CKD patients.
Abstract

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...